🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease

RecruitingPhase 2Ages 18 Years - anyAllFundación Pública Andaluza para la gestión de la …
NCT04478734 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Evaluate the safety and tolerability of combined oral thiamine with biotin therapy in patients with Huntington´s disease in mild to moderate stages and it is intended to evaluate the biological effect of the treatment in the central nervous system of these patients using as the main biomarker the increase in the level of thiamine monophosphate (TMP) in cerebrospinal fluid (CSF) of these patients with Huntington Disease (HD) during a follow-up period of one year. Our main hypothesis is that combined thiamine-biotin oral therapy is a secure and well-tolerated treatment, potentially capable of modifying the disease course or avoiding the progression of symptoms in early-stages HD patients

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients of legal age with manifest Huntington's disease with motor symptoms (chorea, dystonia or bradykinesia) and/or neuropsychiatric; and genetic confirmation of a number of repetitions of the cytosine-adenine-guanine trinucleotide (CAG triplet) in the HTT gene (coding for HTT) greater than or equal to 39 * Patients should be capable of giving informed consent and attending the planned visit of the study. * Women of childbearing age should obtain a negative result in the serum or urine pregnancy test at the screening visit. They must also accept the use of appropriate contraceptive methods during the course of the clinical trial and men who have a partner of childbearing age, accept the use of contraceptive methods Exclusion Criteria: * Medical comorbidities considered clinically significant by the clinical judgment of the investigators. * Pregnancy or lactation * Patients with HD dependents on the basic routine daily life activities (UHDRS TFC \< 7) or a severe cognitive decline. * Active psychosis at the moment of the screening evaluation. * Severe renal failure. * Patients previously treated with thiamine and/or biotin or enrolled in other HD clinical trial with oligonucleotide antisense (IONIS-HTTRX (RG6042).
💊

What it tests

  • Moderate doses of Thiamine y Biotin
  • High doses of Thiamine y Biotin
📍

Where

3 sites
Hospital Universitario de San Sebastián
San Sebastián, Spain
Virgen del Rocío Hospital
Seville, Spain
Hospital Ramón y Cajal
Madrid, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy